Literature DB >> 12824766

Inhibition of retinal ON/OFF systems differentially affects refractive compensation to defocus.

S G Crewther1, D P Crewther.   

Abstract

Hatchling chicks reared with defocusing spectacle lenses compensate for the applied defocus, both refractively and through changes in eye growth, in about 1 week. In this experiment, we show that pharmacological inhibition of the retinal ON or OFF responses to light stimulation with isomers of alpha-aminoadipic acid results in a sign-dependent pattern of interference with the refractive compensation mechanism. An intravitreal injection of 2.5 microM L-alpha-aminoadipic acid inhibited the ERG ON response and inhibited refractive compensation to negative lens defocus, but not to positive or zero power lens defocus. D-alpha-aminoadipic acid in the same dose reduced the retinal OFF response and inhibited refractive compensation to positive lens defocus, but not to negative or zero power lenses. Thus the pharmacological manipulation of induced refractive change suggests that the retinal ON and OFF subsystems play independent roles in the emmetropization process.

Entities:  

Mesh:

Year:  2003        PMID: 12824766     DOI: 10.1097/00001756-200307010-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

1.  The ON/OFF-response in retinopathy of prematurity subjects with myopia.

Authors:  Chi D Luu; Adrian H C Koh; Yvonne Ling
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

2.  Light modulation, not choroidal vasomotor action, is a regulator of refractive compensation to signed optical blur.

Authors:  Melanie J Murphy; David P Crewther; Melinda J Goodyear; Sheila G Crewther
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study.

Authors:  Audrey Chia; Wen Li; Donald Tan; Chi D Luu
Journal:  Doc Ophthalmol       Date:  2013-01-05       Impact factor: 2.379

4.  Image defocus and altered retinal gene expression in chick: clues to the pathogenesis of ametropia.

Authors:  Richard A Stone; Alice M McGlinn; Donald A Baldwin; John W Tobias; P Michael Iuvone; Tejvir S Khurana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

Review 5.  IMI - Report on Experimental Models of Emmetropization and Myopia.

Authors:  David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799

6.  Electrical responses from human retinal cone pathways associate with a common genetic polymorphism implicated in myopia.

Authors:  Xiaofan Jiang; Zihe Xu; Talha Soorma; Ambreen Tariq; Taha Bhatti; Alexander J Baneke; Nikolas Pontikos; Shaun M Leo; Andrew R Webster; Katie M Williams; Christopher J Hammond; Pirro G Hysi; Omar A Mahroo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-20       Impact factor: 12.779

7.  Spatial and temporal dissociation of AQP4 and Kir4.1 expression during induction of refractive errors.

Authors:  Melinda J Goodyear; Sheila G Crewther; Melanie J Murphy; Loretta Giummarra; Agnes Hazi; Barbara M Junghans; David P Crewther
Journal:  Mol Vis       Date:  2010-08-14       Impact factor: 2.367

Review 8.  Temporal integration of visual signals in lens compensation (a review).

Authors:  Xiaoying Zhu
Journal:  Exp Eye Res       Date:  2013-03-05       Impact factor: 3.467

Review 9.  Investigating mechanisms of myopia in mice.

Authors:  Machelle T Pardue; Richard A Stone; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2013-01-07       Impact factor: 3.467

10.  Potassium channel and NKCC cotransporter involvement in ocular refractive control mechanisms.

Authors:  Sheila G Crewther; Melanie J Murphy; David P Crewther
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.